• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Pre-clinical and clinical evaluation of a surface plasmon field-enhanced fluorescence spectroscopy (SPFS) antigen test for det

tetano

Editor, Senior Moderator
J Infect Chemother


. 2024 Aug 27:S1341-321X(24)00236-8.
doi: 10.1016/j.jiac.2024.08.019. Online ahead of print. Pre-clinical and clinical evaluation of a surface plasmon field-enhanced fluorescence spectroscopy (SPFS) antigen test for detecting SARS-CoV-2

Nobuyuki Ashizawa[SUP] 1 [/SUP], Takahiro Takazono[SUP] 2 [/SUP], Kenji Ota[SUP] 3 [/SUP], Yuya Ito[SUP] 4 [/SUP], Tatsuro Hirayama[SUP] 5 [/SUP], Kazuaki Takeda[SUP] 4 [/SUP], Shotaro Ide[SUP] 6 [/SUP], Naoki Iwanaga[SUP] 4 [/SUP], Ayumi Fujita[SUP] 7 [/SUP], Masato Tashiro[SUP] 8 [/SUP], Naoki Hosogaya[SUP] 9 [/SUP], Norihiko Akamatsu[SUP] 3 [/SUP], Kosuke Kosai[SUP] 3 [/SUP], Takeshi Tanaka[SUP] 7 [/SUP], Hironori Kobayashi[SUP] 10 [/SUP], Ryosuke Yamauchi[SUP] 10 [/SUP], Chie Segawa[SUP] 10 [/SUP], Hikaru Koizumi[SUP] 10 [/SUP], Natsumi Taka[SUP] 10 [/SUP], Haretsugu Hishigaki[SUP] 10 [/SUP], Kazuko Yamamoto[SUP] 11 [/SUP], Koichi Izumikawa[SUP] 8 [/SUP], Katsunori Yanagihara[SUP] 3 [/SUP], Hiroshi Mukae[SUP] 4 [/SUP]



Affiliations
Abstract

Introduction: The diagnostic tools of nucleic acid amplification tests and antigen tests have been extensively employed for the detection of Coronavirus disease 2019 (COVID-19). Although the reverse-transcriptase polymerase chain reaction (RT)-PCR test has high sensitivity and specificity, it is a time-consuming and labor-intensive process. On the other hand, antigen tests are simple and prompt, however, their low sensitivity and potential for false positives have been identified as limitations. In light of these factors, the development of novel tests that combine speed and clinical dependability is a promising prospect.
Methods: Surface plasmon field-enhanced fluorescence spectroscopy (SPFS) excites chromophores by means of an enhanced electromagnetic field induced on a gold film surface. It enables the highly sensitive measurement of biomarkers in a short and simple 20-min window. In this study, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SPFS-based antigen test targeting the SARS-CoV-2 nucleocapsid protein was performed and evaluated in 25 patients with COVID-19 and 10 non-infected controls.
Results: A positive correlation was observed between antigen levels determined by SPFS and RNA levels determined via RT-PCR. The sensitivity values were 100 %, 92 %, and 62.5 %; and the specificity values were 100 %, 90 %, and 100 %; for nasopharyngeal swabs, nasal swabs, and saliva specimens when the cutoff values were set to 65.1, 0.2, and 1.5 pg/mL, respectively. No clinically problematic cross-reactivity with analogous coronaviruses was observed.
Conclusions: The SARS-CoV-2 SPFS antigen test showed excellent clinical diagnostic accuracy for nasopharyngeal and nasal swabs, with a rapid turnaround.

Keywords: COVID-19; Diagnostic accuracy; PCR; Rapidity; SPFS.

 
Back
Top Bottom